One of the reasons research into medical cannabis has leapt so high in recent years is that the plant itself is remarkably complex. There are 142 different “cannabinoids” – active components – in cannabis that can target different illnesses.
The two best known are THC, the main psychoactive ingredient that also treats pain and nausea; and CBD, which is non-hallucinogenic and works on the autoimmune system.
The cannabis plant also contains terpenes, fragrant oils that provide a distinctive flavor and aroma. Many cannabis blends are named after their terpenes, which can provide a “blueberry” or “sour diesel” taste, for instance.
Israeli medical cannabis company Bazelet announced this week that it has developed proprietary technology to isolate and utilize specific terpenes to treat specific ailments, including chronic pain, post-traumatic stress disorder (PTSD), neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases, epilepsy and autism.
Bazelet says its technology can “improve the therapeutic quality